Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Principles for designing an optimal mRNA lipid nanoparticle vaccine
Edo Kon, Uri Elia, Dan Peer
Current Opinion in Biotechnology (2021) Vol. 73, pp. 329-336
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 405
Nanodelivery of nucleic acids
Bárbara B. Mendes, João Conniot, Aviram Avital, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 349
RNA-based therapeutics: an overview and prospectus
Yiran Zhu, Liyuan Zhu, Xian Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 344
COVID-19 mRNA vaccines: Platforms and current developments
Gábor Szabó, Azita J. Mahiny, Irena Vlatkovic
Molecular Therapy (2022) Vol. 30, Iss. 5, pp. 1850-1868
Open Access | Times Cited: 194
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
Edo Kon, Nitay Ad‐El, Inbal Hazan‐Halevy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 739-754
Open Access | Times Cited: 127
Nanotechnology-based strategies against SARS-CoV-2 variants
Xiangang Huang, Edo Kon, Xuexiang Han, et al.
Nature Nanotechnology (2022) Vol. 17, Iss. 10, pp. 1027-1037
Open Access | Times Cited: 102
mRNA vaccines for cancer immunotherapy
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
Michaela Jeong, Yeji Lee, Jeongeun Park, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 114990-114990
Closed Access | Times Cited: 87
Endosomal escape: A bottleneck for LNP-mediated therapeutics
Sushmita Chatterjee, Edo Kon, Preeti Sharma, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 11
Open Access | Times Cited: 85
The Unexpected Importance of the Primary Structure of the Hydrophobic Part of One-Component Ionizable Amphiphilic Janus Dendrimers in Targeted mRNA Delivery Activity
Dapeng Zhang, Elena N. Atochina‐Vasserman, Juncheng Lu, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 11, pp. 4746-4753
Closed Access | Times Cited: 77
Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Biodegradable Cationic and Ionizable Cationic Lipids: A Roadmap for Safer Pharmaceutical Excipients
Arne Matteo Jörgensen, Richard Wibel, Andreas Bernkop‐Schnürch
Small (2023) Vol. 19, Iss. 17
Open Access | Times Cited: 52
Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
Jisun Lee, Matthew C. Woodruff, Eui Ho Kim, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1305-1313
Open Access | Times Cited: 50
Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid
Yaru Jia, Xiu‐Guang Wang, Luwei Li, et al.
Advanced Materials (2023) Vol. 36, Iss. 4
Closed Access | Times Cited: 46
Engineering nanoparticle toolkits for mRNA delivery
Bing Sun, Weixi Wu, Eshan A. Narasipura, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115042-115042
Open Access | Times Cited: 45
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
Sarah J. Shepherd, Xuexiang Han, Alvin J. Mukalel, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 33
Open Access | Times Cited: 43
A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium
Edo Kon, Yinon Levy, Uri Elia, et al.
Science Advances (2023) Vol. 9, Iss. 10
Open Access | Times Cited: 42
The immunostimulatory nature of mRNA lipid nanoparticles
Preeti Sharma, Daniek Hoorn, Anjaiah Aitha, et al.
Advanced Drug Delivery Reviews (2024) Vol. 205, pp. 115175-115175
Open Access | Times Cited: 34
Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives
Eliana B. Souto, Cristina Blanco-Llamero, Karolline Krambeck, et al.
Acta Biomaterialia (2024) Vol. 180, pp. 1-17
Open Access | Times Cited: 27
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Zhe Sun, Hui Zhao, Li Ma, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 16
Exosome for mRNA delivery: strategies and therapeutic applications
Zoya Iqbal, Khurrum Rehman, Ayesha Mahmood, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Lipid Nanoparticle Technologies for Nucleic Acid Delivery: A Nanoarchitectonics Perspective
Abdul Rahim Ferhan, Soo-Hyun Park, Hyeonjin Park, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 37
Closed Access | Times Cited: 63
Recent Advances in Lipid Nanoparticles for Delivery of mRNA
Lei Yang, Liming Gong, Ping Wang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2682-2682
Open Access | Times Cited: 62
Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines
Byungji Kim, Ryan R. Hosn, Tanaka Remba, et al.
Journal of Controlled Release (2022) Vol. 353, pp. 241-253
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top